MML Investors Services
RVMD icon

MML Investors Services’s Revolution Medicines RVMD Stock Holding History

MML Investors Services’s Portfolio RVMD Stock Details RVMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$473K Buy
+2,525
New +$369K ﹤0.01% 2504

Other funds holding RVMD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
AI
Alphabet Inc Mountain View, California $99.1B AUM 124.46% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM

MML Investors Services's RVMD Position: Q2 2026 in Review

MML Investors Services opened a new position in Revolution Medicines (RVMD) in Q2 2026: 2,525 shares worth $473K. The stake represents ﹤0.01% of the portfolio and ranks #2504 among its holdings.

483 funds tracked by Wall St. Rank hold RVMD as of Q2 2026.

  • MML Investors Services held 2,525 shares of Revolution Medicines worth $473K as of Q2 2026.
  • Revolution Medicines was a new MML Investors Services position in Q2 2026.
  • Revolution Medicines made up ﹤0.01% of MML Investors Services's portfolio in Q2 2026, its #2504 holding.
  • 483 funds tracked by Wall St. Rank held Revolution Medicines as of Q2 2026.

Based on MML Investors Services's 13F filing for Q2 2026, filed 7 Aug 2026.